Áttétes vesedaganatos betegek kabozantinibterápiájának multicentrikus magyarországi eredményei
The aim of our analysis was to evaluate the efficacy of cabozantinib in patients with metastatic renal cell carcinoma. Cabozantinib therapy initiated between 01/01/2019 and 31/12/2022 was evaluated based on a retrospective review of data from 14 renal centers in Hungary. The starting dose was 60 or...
Elmentve itt :
| Szerzők: | |
|---|---|
| Dokumentumtípus: | Cikk |
| Megjelent: |
2023
|
| Sorozat: | MAGYAR ONKOLÓGIA
67 No. 1 |
| Tárgyszavak: | |
| mtmt: | 33791187 |
| Online Access: | http://publicatio.bibl.u-szeged.hu/26901 |